'Type 2 diabetes' is considered as one of the major diseases of this century. There are millions of people in the world are suffering from this disease and the worst thing about this disease is it can not be cured. So far, doctors and scientists thought that this disease only can be managed with quality lifestyle and medication system. If the things get bad then there will be a necessity of bariatric surgery in order to get the things back on track.
But recently scientists and doctors have gone through a study and the study shows that the complete cure of the disease is possible. The medical course which is needed to be taken is very short termed. At the same time, it is expected that this treatment can cure a significant number of patients.
The medication system includes different oral medicines and insulins. This medication system has successfully worked in the 40 percent of patients. At the same time, the diabetes of those patients has been cured within the three moths. This incident has really inspired the researchers.
The main reason of the 'Type-2 diabetes is the insulin hormone. The patient who is suffering from type-2 diabetes does not produce enough insulin hormones. The insulin hormones help people to absorb glucose and it controls the blood sugar level in our body. When the level of hormone is reduced then the blood sugar level automatically goes up.
According to HealthDay News, There is about 29 millions of people in the United States are suffering from Type-2 diabetes. The current cost to treat those patients is approximately around 512 billion USD. Therefore, it can be understood that the current health system is in a desperate need which can produce a new way to treat type-2 diabetes which will be more affordable.
Therefore, this new research brings new hope to the type-2 diabetes patients. With proper diet plans and medications, it can be expected that this chronic disease can be treated effectively.
Recent Studies Reveal 'Type 2 Diabetes' Can Be Treated in 40 Percent of Patients
© 2024 HNGN, All rights reserved. Do not reproduce without permission.
Editor's Pick